Bucillamine (DE019) protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of VEGF. Bucillamine is an orally active sulfhydryl donor and antioxidant with antirheumatic and antiangiogenic properties. Bucillamine can be used for studies about choroidal neovascularization and rheumatoid arthritis.
Molecular Weight:
223.31
Purity:
98.66%
CAS Number:
[65002-17-7]
Formula:
C7H13NO3S2
Target:
VEGFR|||Antioxidant
T21334
* VAT and and shipping costs not included. Errors and price changes excepted